INS and acromegaly: To our knowledge, this Phase IV trial is the first prospective study designed to assess the efficacy of incretin-based therapy versus insulin for the management of pasireotide-associated hyperglycemia that is not fully controlled despite treatment with metformin or other non-incretin-based oral antidiabetic drugs (OADs) in patients with acromegaly or Cushing’s disease.